Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
In development
In development: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Expected publication date
Expected publication date
From date
To date
Apply date filters
Area of interest
Area of interest
COVID-19 (9)
Type
Type
Guidance (430)
NICE advice (2)
Quality standard (9)
Guidance programme
Guidance programme
Clinical guidelines (27)
Diagnostics guidance (10)
Health technology evaluations (20)
HealthTech guidance (2)
Highly specialised technologies guidance (6)
Interventional procedures guidance (17)
Medical technologies guidance (10)
NICE guidelines (32)
Public health guidelines (1)
Technology appraisal guidance (345)
Advice programme
Advice programme
Medtech innovation briefings (1)
NICE reviews (1)
Apply filters
Showing 426 to 441 of 441
Sort by
Title
Date
Apply sorting
Guidance, NICE advice and quality standards in development
Title
Type
Expected publication date
Vibostolimab–pembrolizumab for untreated PD-L1-positive metastatic non-small-cell lung cancer [ID6382]
Technology appraisal guidance
TBC
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable TSID 12099
Technology appraisal guidance
TBC
Violence and Aggression (update)
Quality standard
28 January 2027
Vocimagene amiretrorepvec with extended-release 5-fluorocytosine for treating recurrent high-grade glioma [ID1425]
Technology appraisal guidance
TBC
Vorasidenib for treating astrocytoma or oligodendroglioma with IDH1 or IDH2 mutations after surgery in people 12 years and over [ID6407]
Technology appraisal guidance
28 January 2026
Vosoritide for treating achondroplasia in people 4 months and over [ID6488]
Technology appraisal guidance
TBC
VTS-270 for treating Niemann-Pick type C1 [ID1267]
Highly specialised technology
TBC
Waldenstrom's macroglobulinaemia - ibrutinib [ID884]
Technology appraisal guidance
22 November 2017
Women's and reproductive health guidelines
NICE guideline
TBC
Xevinapant with platinum-based chemotherapy and radiotherapy for untreated locally advanced squamous cell head and neck cancer [ID6199]
Technology appraisal guidance
TBC
Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments [ID6388]
Technology appraisal guidance
14 May 2026
Zanubrutinib for untreated chronic lymphocytic leukaemia [ID5079]
Technology appraisal guidance
TBC
Zilucoplan for treating antibody positive generalised myasthenia gravis [ID4008]
Technology appraisal guidance
TBC
Zio XT for detecting cardiac arrhythmias
Medical technologies guidance
TBC
Zuranolone for treating postnatal depression [ID6431]
Technology appraisal guidance
TBC
Venoarterial Extracorporeal membrane oxygenation (VA ECMO) for postcardiotomy cardiogenic shock in adults
Interventional procedures guidance
29 January 2026
Previous page
1
…
16
17
Current page
18
Page
18
of
18
Results per page
10
25
50
All
Back to top